Multiple sclerosis in a family on the Faroe Islands

Acta Neurologica Scandinavica

Volumn 121, Issue 1, 2010, Pages 16-19

  Binzer, S ^a,b   Imrell, K ^c   Binzer, M ^b   Vang, S ^d   Rogvi Hansen, B ^e,f   Hillert, J ^b   Stenager, E ^b,g  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b MS clinic of Southern Denmark ^*  (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Genetic Biobank   (Faroe Islands)

^e Queen Alexandrines Hospital/Landssjukrahusid   (Faroe Islands)

^f Rigshospitalet   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Faroe Islands; Isolated population; Kurtzke's theory; Multiple sclerosis

Indexed keywords

HLA DR15 ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FAROE ISLANDS; GENE FREQUENCY; HAPLOTYPE; HLA TYPING; HUMAN; MORBIDITY; MULTIPLE SCLEROSIS; ONSET AGE; PEDIGREE; RELAPSE; REMISSION;

ADULT; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PEDIGREE; PREVALENCE; YOUNG ADULT;

EID: 74049160030     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01291.x     Document Type: Article

References (14)

1. Svejgaard A. The immunogenetics of multiple sclerosis. Immunogenetics 2008 60 : 275 286.
2. Kallio SP, Jakkula E, Purcell S et al. Use of genetic isolate to identify rare disease variants: C7 on 5p associated with MS. Hum Mol Genet 2009 18 : 1670 1683.
3. Hoppenbrouwers IA, Aulchenko YS, Ebers GC et al. EV15 is a risk gene for multiple sclerosis. Genes Immun 2008 9 : 334 337.
4. Hoppenbrouwers I, Cortes LM, Aulchenko YS et al. Familial clustering of multiple sclerosis in a Dutch genetic isolate. Mult Scler 2007 13 : 17 24.
5. Kurtzke JF. Some epidemiologic features compatible with an infectious origin for multiple sclerosis. Int Arch Allergy Appl Immunol 1969 36 (Suppl. 59 82.
6. Kurtzke JF, Hyllested K. Multiple sclerosis: an epidemic disease in the Faeroes. Trans Am Neurol Assoc 1975 100 : 213 215.
7. Kurtzke JF. Multiple sclerosis and infection from an epidemiologic aspect. Neurology 1968 18 : 170 175.
8. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993 6 : 382 427.
9. Kurtzke JF, Heltberg A. Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 2001 54 : 1 22.
10. Poser CM, Hibberd PL, Benedikz J, Gudmundsson G. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects. Neuroepidemiology 1988 7 : 168 180.
11. Poser CM, Hibberd PL. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. II. Biostatistical aspects. Neuroepidemiology 1988 7 : 181 189.
12. Prat E. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J Neuroimmunol 2005 167 : 108 119.
13. Jersild C, Kurtzke JF, Riisom K, Heltberg A, Arbuckle J, Hyllested K. Multiple sclerosis in the Faroe Islands. VI. Studies of HLA markers. Tissue Antigens 1993 42 : 105 110.
14. Ballerini C, Guerini FR, Rombolà G et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004 150 : 178 185.